293 related articles for article (PubMed ID: 30154315)
21. A quality by design approach for the development of lyophilized liposomes with simvastatin.
Porfire A; Muntean DM; Rus L; Sylvester B; Tomuţă I
Saudi Pharm J; 2017 Nov; 25(7):981-992. PubMed ID: 29158704
[TBL] [Abstract][Full Text] [Related]
22. Effect of sucrose as a lyoprotectant on the integrity of paclitaxel-loaded liposomes during lyophilization.
Kannan V; Balabathula P; Thoma LA; Wood GC
J Liposome Res; 2015; 25(4):270-8. PubMed ID: 25534990
[TBL] [Abstract][Full Text] [Related]
23. The Effect of Formulation, Process, and Method Variables on the Reconstitution Time in Dual Chamber Syringes.
Werk T; Ludwig IS; Mahler HC; Luemkemann J; Huwyler J; Hafner M
PDA J Pharm Sci Technol; 2016 11/12; 70(6):508-522. PubMed ID: 27974591
[TBL] [Abstract][Full Text] [Related]
24. Facts and evidences on the lyophilization of polymeric nanoparticles for drug delivery.
Fonte P; Reis S; Sarmento B
J Control Release; 2016 Mar; 225():75-86. PubMed ID: 26805517
[TBL] [Abstract][Full Text] [Related]
25. Effect of controlled ice nucleation on primary drying stage and protein recovery in vials cooled in a modified freeze-dryer.
Passot S; Tréléa IC; Marin M; Galan M; Morris GJ; Fonseca F
J Biomech Eng; 2009 Jul; 131(7):074511. PubMed ID: 19640147
[TBL] [Abstract][Full Text] [Related]
26. Freeze-dried cake structural and physical heterogeneity in relation to freeze-drying cycle parameters.
Badal Tejedor M; Fransson J; Millqvist-Fureby A
Int J Pharm; 2020 Nov; 590():119891. PubMed ID: 33010400
[TBL] [Abstract][Full Text] [Related]
27. Determination of mass and heat transfer parameters during freeze-drying cycles of pharmaceutical products.
Hottot A; Vessot S; Andrieu J
PDA J Pharm Sci Technol; 2005; 59(2):138-53. PubMed ID: 15971546
[TBL] [Abstract][Full Text] [Related]
28. Polymyxin E sulfate-loaded liposome for intravenous use: preparation, lyophilization, and toxicity assessment in vivo.
Wang D; Kong L; Wang J; He X; Li X; Xiao Y
PDA J Pharm Sci Technol; 2009; 63(2):159-67. PubMed ID: 19634354
[TBL] [Abstract][Full Text] [Related]
29. Freeze-Drying From Organic Co-Solvent Systems, Part 2: Process Modifications to Reduce Residual Solvent Levels and Improve Product Quality Attributes.
Kunz C; Schuldt-Lieb S; Gieseler H
J Pharm Sci; 2019 Jan; 108(1):399-415. PubMed ID: 30017885
[TBL] [Abstract][Full Text] [Related]
30. The Impact of Formulation Composition and Process Settings of Traditional Batch Versus Continuous Freeze-Drying On Protein Aggregation.
Vanbillemont B; Carpenter JF; Probst C; De Beer T
J Pharm Sci; 2020 Nov; 109(11):3308-3318. PubMed ID: 32739274
[TBL] [Abstract][Full Text] [Related]
31. Optimization of the different phases of the freeze-drying process of solid lipid nanoparticles using experimental designs.
Elbrink K; Van Hees S; Holm R; Kiekens F
Int J Pharm; 2023 Mar; 635():122717. PubMed ID: 36781084
[TBL] [Abstract][Full Text] [Related]
32. Lyophilization of protein formulations in vials: investigation of the relationship between resistance to vapor flow during primary drying and small-scale product collapse.
Overcashier DE; Patapoff TW; Hsu CC
J Pharm Sci; 1999 Jul; 88(7):688-95. PubMed ID: 10393566
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of spin freezing versus conventional freezing as part of a continuous pharmaceutical freeze-drying concept for unit doses.
De Meyer L; Van Bockstal PJ; Corver J; Vervaet C; Remon JP; De Beer T
Int J Pharm; 2015 Dec; 496(1):75-85. PubMed ID: 25981618
[TBL] [Abstract][Full Text] [Related]
34. Formulation kit for liposomal doxorubicin composed of lyophilized liposomes.
Stevens PJ; Lee RJ
Anticancer Res; 2003; 23(1A):439-42. PubMed ID: 12680245
[TBL] [Abstract][Full Text] [Related]
35. Freezing process influences cake appearance of a lyophilized amorphous protein formulation with low solid content and high fill configuration.
Lu X; Kulkarni SS; Dong H; Tang Y; Yi L; Gupta S
Int J Pharm; 2023 Apr; 636():122803. PubMed ID: 36894041
[TBL] [Abstract][Full Text] [Related]
36. Applications of Headspace Moisture Analysis for Investigating the Water Dynamics within a Sealed Vial Containing Freeze-dried Material.
Cook IA; Ward KR
PDA J Pharm Sci Technol; 2011; 65(1):2-11. PubMed ID: 21414935
[TBL] [Abstract][Full Text] [Related]
37. Impact of formulation on the quality and stability of freeze-dried nanoparticles.
Luo WC; O'Reilly Beringhs A; Kim R; Zhang W; Patel SM; Bogner RH; Lu X
Eur J Pharm Biopharm; 2021 Dec; 169():256-267. PubMed ID: 34732383
[TBL] [Abstract][Full Text] [Related]
38. The effect of loading process on product collapse during large-scale lyophilization.
Wallen AJ; Van Ocker SH; Sinacola JR; Phillips BR
J Pharm Sci; 2009 Mar; 98(3):997-1004. PubMed ID: 18661543
[TBL] [Abstract][Full Text] [Related]
39. Freeze-drying of nanoparticles: How to overcome colloidal instability by formulation and process optimization.
Trenkenschuh E; Friess W
Eur J Pharm Biopharm; 2021 Aug; 165():345-360. PubMed ID: 34052428
[TBL] [Abstract][Full Text] [Related]
40. Protective Effect of Saccharides on Freeze-Dried Liposomes Encapsulating Drugs.
Guimarães D; Noro J; Silva C; Cavaco-Paulo A; Nogueira E
Front Bioeng Biotechnol; 2019; 7():424. PubMed ID: 31921827
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
